179737-68-9

Upstream product

• 94807-88-2 1-Methyl-2,3-bis(trifluoromethyl)-7-oxabicyclo<2.2.1>hepta-2,5-diene 

Downstream Products

• 280753-15-3 4-(4-bromobenzenesulfonyloxy)-2,3-bis(trifluoromethyl)benzyl bromide 
• 381229-86-3 4-trifloxy-2,3-bis(trifluoromethyl)benzaldehyde 
• 381229-87-4 4-(2-methoxy-phenylsulfanyl)-2,3-bis-trifluoromethyl-benzaldehyde 
• 280753-16-4 4-hydroxy-2,3-bis(trifluoromethyl)benzaldehyde 

Relevant academic research and scientific papers

Polyhalogenated heterocyclic compounds. Part 41. Cycloaddition reactions involving hexafluorobut-2-yne and 1,1,1,12,4,4,4-heptafluorobut-2-ene

Cycloadducts, formed by addition of hexafluorobut-2-yne, may be transformed into bis(trifluoromethyl)-benzene, -phenol and -furan derivatives. Tetrakis(trifluoromethyl)benzene may also be produced. Heptafluorobut-2-ene 2 is also a very efficient dienophil

Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds

The present invention relates to novel cinnamide compounds that are useful for treating inflammatory and immunune diseases, to pharmaceutical compositions containing these compounds, and to methods of inhibiting inflammation or suppressing immune response in a mammal.

Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds

The present invention relates to novel cinnamide compounds that are useful for treating inflammatory and immune diseases and cerebral vasospasm, to pharmaceutical compositions containing these compounds, and to methods of inhibiting inflammation or suppressing immune response in a mammal.